08 Jul 2013 Posted in
Last week ABPI members heard the latest research into the behaviours of patients in taking their medicines and were presented with opportunities around industry’s role in patient adherence.
Speakers included: Clare Howard, Deputy Chief Pharmaceutical Officer NHS England; John Wienman, Professor of Psychology as Applied to Medicines, King’s College London; Graham Davies, Professor of Clinical Pharmacy and Therapeutics, King’s College London; Chris Boulton, Director Marketing and Medicines Access, AstraZeneca UK; and Andy Carter, Director of Strategy, Atlantis Healthcare.
Clare Howard highlighted how you rarely achieve the ‘Holy Grail’ of 80 per cent adherence with a patient. She said:
“Our default position currently is that patients will take medicine as prescribed. Perhaps we should assume they won’t, because the evidence tells us that they won’t take the meds as intended. So what can we do to support the patient to take the meds appropriately?”
John Wienman discussed an insight into the reasons that patients neglect to take their medicines as prescribed. Graham Davies, Chris Boulton and Andy Carter also added to the debate covering developments in the understanding of adherence and providing real life examples of how the pharmaceutical industry can play a role.
A more detailed report of the ABPI meeting and an opportunity to share thoughts around this will be available within the next two weeks in the Patient Engagement area of the PM Society website www.pmsociety.org/patientengagement or email the Society via the website to be alerted when it goes live.
For more information, please contact Katie Crumpton, ABPI Membership Services Officer (email firstname.lastname@example.org).